R
Rubius Therapeutics
Biotech & Life Sciences · Cambridge, United States · Founded 2013 · IPO 2018
Focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases through its rubius erythrocyte design cellular therapy platform MoreLess
Rubius Therapeutics is a biotechnology company focused on developing innovative cellular therapies by transforming red blood cells into medicines. The company primarily serves patients with cancer and autoimmune diseases, aiming to provide life-changing treatments. Operating in the biopharmaceutical market, Rubius Therapeutics leverages its deep scientific expertise and dedicated team to advance its pipeline of promising drug candidates. The business model revolves around the research, development, and commercialization of these cellular therapies. Revenue is generated through the successful development and sale of these therapies, as well as potential partnerships and collaborations with other pharmaceutical companies.
Keywords: cellular therapies, red blood cells, cancer treatment, autoimmune diseases, biotechnology, biopharmaceutical, drug development, clinical trials, innovative medicine, scientific expertise.
Talent graph
Rubius Therapeutics's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Rubius Therapeutics has talent and traffic
team presence
across markets
Patent intelligence
$1M patent portfolio · 11 active families
Where Rubius Therapeutics concentrates vs peers
Each axis is a top-10 topic across Rubius Therapeutics and its closest peers. #1 = 100, #10 = 10, absent = 0.
Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.
Market sentiment
What the market is saying about Rubius Therapeutics
An AI-synthesized read of the highest-engagement posts about Rubius Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Rubius Therapeutics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.